Integration of bulk and single-cell transcriptomic sequencing reveals the neutrophil heterogeneity in bladder cancer and establishes a prognostic model

Key Points

• Neutrophil heterogeneity in bladder cancer was established using bulk and single-cell transcriptomic sequencing, offering new insights.
• The study identifies a prognostic model based on neutrophil characteristics that may aid in patient management.
• Assessment involved integration of both bulk and single-cell transcriptomic sequencing to analyze neutrophil variations effectively.
• Utilizing this model supports personalized treatment strategies but may require validation in larger, diverse cohorts.